PV Bulletin

Nature's Own Glucosamine Sulfate with Chondroitin and Nature's Own Magnesium Glycinate 1150mg Recall by Sanofi Consumer Healthcare

Sanofi Consumer Healthcare recalls Nature's Own Glucosamine Sulfate with Chondroitin (320 pack) and Nature's Own Magnesium Glycinate 1150mg (300 pack) due to potential presence of glass fragments in the bottle.

Primary source: https://www.tga.gov.au/safety/recalls-and-other-market-actions/market-actions/natures-own-glucosamine-sulfate-chondroitin-and-natures-own-magnesium-glycinate-1150mg

PV Impact Brief

Urgency: HighConfidence: high

What changed

Recall initiated for Nature's Own Glucosamine Sulfate with Chondroitin (batch 1662937) and Nature's Own Magnesium Glycinate 1150mg (batch 1665576) due to glass fragments.

Why it matters

Glass fragments can cause injury when handling product or harm if accidentally swallowed, requiring immediate consumer action.

Action needed

Return recalled products to place of purchase for refund or contact Customer Care for return arrangements.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

one-time

Regulatory action details

Action type
Recall
Publication date
2026-06-03
Safety issue
Recall due to the potential presence of glass fragments in specific batches of supplements.

Affected products

  • Nature's Own Glucosamine Sulfate with Chondroitin
    Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
  • Nature's Own Magnesium Glycinate 1150mg
    Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
    1665576

PV internal implications

Consumers should stop using the product and return it to the place of purchase for a full refund.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 3, 2026

Full briefing

Practical implication

Return recalled products to place of purchase for refund or contact Customer Care for return arrangements.

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare is recalling two products due to potential glass fragments in the bottle, posing cut and ingestion hazards.

What changed: Recall initiated for Nature's Own Glucosamine Sulfate with Chondroitin (batch 1662937) and Nature's Own Magnesium Glycinate 1150mg (batch 1665576) due to glass fragments.

Why it matters: Glass fragments can cause injury when handling product or harm if accidentally swallowed, requiring immediate consumer action.

Practical implication: Return recalled products to place of purchase for refund or contact Customer Care for return arrangements.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Recall#Safety Signal#Safety Signals#firecrawl-agent#regulatory-extraction#Recalls#Therapeutic Goods Administration (TGA)

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward